Buscador de publicacions

Publicacions

  • Laiglesia LM, Escoté X, Sáinz N, Felix-Soriano E, Santamaría E, Collantes M, Fernández-Galilea M, Colón-Mesa I, Martínez-Fernández L, Quesada T, Quesada-Vázquez S, Rodríguez-Ortigosa C, Arbones-Mainar JM, Valverde ÁM, Martínez JA, Dalli J, LAURA HERRERO RODRÍGUEZ, Lorente-Cebrián S, Villarroya-Gombau F and Moreno-Aliaga MJ.

    Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice.

    molecular metabolism . 74: 101749-101749. Nº de cites: 5

    [doi:10.1016/j.molmet.2023.101749]

  • Soria-Gondek A, Fernández-García P, González L, Reyes-Farias M, Murillo M, Valls A, Real N, Pellitero S, Tarascó J, Jenkins B, Galán M, Villarroya-Gombau F, Koulman A, Corrales P, Vidal-Puig A, Cereijo R and Sánchez-Infantes D.

    Lipidome Profiling in Childhood Obesity Compared to Adults: A Pilot Study.

    Nutrients . 15(15): .

    [doi:10.3390/nu15153341]

  • Castellá M, Blasco-Roset A, Peyrou M, Gavaldà-Navarro A, Villarroya-Terrade J, Quesada T, Lorente-Poch L, Sancho J, Szymczak F, Piron A, Rodríguez-Fernández S, Carobbio S, Goday A, Domingo P, Vidal-Puig A, Giralt M, Eizirik DL, Villarroya-Gombau F and Cereijo R.

    Adipose tissue plasticity in pheochromocytoma patients suggests a role of the splicing machinery in human adipose browning

    iScience . 26(6): 106847-106847.

    [doi:10.1016/j.isci.2023.106847]

  • García-Beltran C, Navarro-Gascon, A, Lopez-Bermejo, A, Quesada-Lopez, T, de Zegher, F, Ibañez-Toda L and Villarroya-Gombau F.

    Meteorin-like levels are associated with active brown adipose tissue in early infancy

    Frontiers in Endocrinology . 14: 1136245-1136245.

    [doi:10.3389/fendo.2023.1136245]

  • Díaz-Silva M, Carreras-Badosa G, Villarroya-Terrade J, Gavaldà-Navarro A, Bassols-Casadevall J, de Zegher F, López-Bermejo A, Villarroya-Gombau F and Ibañez-Toda L.

    Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment.

    PEDIATRIC RESEARCH . 93(4): 964-968. Nº de cites: 2

    [doi:10.1038/s41390-022-02175-9]

  • Quesada T, Cereijo R, Blasco-Roset A, Mestres-Arenas A, Prieto P, Domingo JC, Villarroya-Gombau F, Domingo P and Giralt M.

    Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function.

    BIOCHEMICAL PHARMACOLOGY . 220: 116010-116010.

    [doi:10.1016/j.bcp.2023.116010]

  • Domingo P, Giralt M, Gavaldà-Navarro A, Blasco-Roset A, Delgado-Anglés A, Gallego-Escuredo JM, Gutiérrez MDM, Mateo MG, Cereijo R, Domingo JC, Villarroya-Gombau F and Villarroya-Terrade J.

    Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy.

    Adipocyte . 11(1): 143-152. Nº de cites: 1

    [doi:10.1080/21623945.2022.2042962]

  • Paterson, HAB, Yu, SJ, Artigas, N, Prado, MA, Haberman, N, Wang, YF, Jobbins, AM, Pahita, E, Mokochinski, J, Hall, Z, Guerin, M, Paulo, JA, Ng, SS, Villarroya-Gombau F, Rashid, ST, Le Goff, W, Lenhard, B, Cebola, I, Finley, D, Gygi, SP, Sibley, CR and Vernia, S.

    Liver RBFOX2 regulates cholesterol homeostasis via Scarb1 alternative splicing in mice

    Nature Metabolism . 4(12): 1812. Nº de cites: 4

    [doi:10.1038/s42255-022-00681-y]

  • Domingo P, Quesada-López T, Villarroya-Terrade J, Cairo M, Gutierrez MDM, Mateo MG, Mur I, Corbacho N, Domingo JC, Villarroya-Gombau F and Giralt M.

    Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes.

    LIFE SCIENCES . 308: 120948-120948. Nº de cites: 2

    [doi:10.1016/j.lfs.2022.120948]

  • Latorre J, Díaz-Trelles R, Comas F, Gavaldà-Navarro A, Milbank E, Dragano N, Morón S, Mukthavaram R, Ortega F, Castells-Nobau A, Oliveras-Cañellas N, Ricart W, Karmali PP, Tachikawa K, Chivukula P, Villarroya-Gombau F, López M, Giralt M, Fernández-Real JM and Moreno-Navarrete JM.

    Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation.

    MOLECULAR THERAPY-NUCLEIC ACIDS . 29: 599-613. Nº de cites: 5

    [doi:10.1016/j.omtn.2022.08.003]